| Olanzapine |
№ II -10963/12.10.2010 |
Olstadryn, Film coated tablet, 5 mg, -, Pack: 30 |
Stada Arzneimittel AG, Германия |
Actavis hf.Исландия, Actavis Малта,Centrafarm Services B.V Холандия,Clonmel Healthcare Ирландия,LAMP S.Pospero Италия,Parma Co Dane ApS.Дания, STADA Arzneimittel AG Германия,STADA Arzneimittel GmbH Австрия |
38.14 |
7.63 |
45.77 |
4% |
1.53 |
39.67 |
7.93 |
47.6 |
16% |
6.1 |
45.77 |
9.15 |
54.92 |
КЦ-1959/
25,01,2011 г. |
24.02.2011 |
24.02.2011 |
|
|
Активен |
7594 |
| Omega-3-triglycerides |
20040231 |
OMACOR, capsule soft, 1000 mg, -, Pack: 28 |
Pronova Biocare a.s., Норвегия |
Pronova Biocare a.s., Norway, Pierre Fabre Medicament Production, France |
18.07 |
3.61 |
21.68 |
6% |
1.08 |
19.15 |
3.83 |
22.98 |
18% |
3.25 |
22.4 |
4.48 |
26.88 |
Комисия по прозрачност оставя без разглеждане жалбата с решение КП-208/30.04.2015 и НСР-1259/25.09.2013 |
02.06.2015 |
02.06.2015 |
|
|
Активен |
9064 |
| Highly refined fish oil, Purified egg phosphatide, Glycerol |
20040577 |
Omegaven, Emulsion for infusion, 100, ml, Pack: 10 |
Fresenius Kabi Deutschland GmbH, Германия |
Fresenius Kabi Austria GmbH, Австрия |
361.83 |
72.37 |
434.2 |
4% |
10 |
371.83 |
74.37 |
446.2 |
16% |
25 |
396.83 |
79.37 |
476.2 |
НСР-9752/14.07.2016; НСР-18323/28.03.2019 |
02.08.2016 |
02.05.2019 |
|
|
Заличен |
15300 |
| Highly refined fish oil, Purified egg phosphatide, Glycerol |
20040577 |
Omegaven, Emulsion for infusion, 100, ml, Pack: 10 |
Fresenius Kabi Deutschland GmbH, Германия |
Fresenius Kabi Austria GmbH, Австрия |
361.83 |
72.37 |
434.2 |
4% |
10 |
371.83 |
74.37 |
446.2 |
16% |
25 |
396.83 |
79.37 |
476.2 |
НСР-9752/14.07.2016 |
02.08.2016 |
02.08.2016 |
|
|
Неактивен |
15300 |
| Omeprazole |
20070040 |
Omeprazole Genericon, Gastro resistant capsule, hard, 20, mg, Pack: 28 |
Genericon Pharma GmbH, Австрия |
Genericon Pharma GmbH, Австрия |
8.37 |
1.67 |
10.04 |
7% |
0.59 |
8.96 |
1.79 |
10.75 |
20% |
1.67 |
10.63 |
2.13 |
12.76 |
НСР-9506/09.06.2016; НСР-16879/28.09.2018 |
13.10.2018 |
02.12.2018 |
Корекционно решение НСР-17282/14.11.2018 |
|
Активен |
15111 |
| Omeprazole |
20070040 |
Omeprazole Genericon, Gastro resistant capsule, hard, 20, mg, Pack: 28 |
Genericon Pharma GmbH, Австрия |
Genericon Pharma GmbH, Австрия |
8.37 |
1.67 |
10.04 |
7% |
0.59 |
8.96 |
1.79 |
10.75 |
20% |
1.67 |
10.63 |
2.13 |
12.76 |
НСР-9506/09.06.2016; НСР-16879/28.09.2018 |
13.10.2018 |
02.11.2018 |
|
|
Неактивен |
15111 |
| Omeprazole |
20070040 |
Omeprazole Genericon, Gastro resistant capsule, hard, 20, mg, Pack: 28 |
Genericon Pharma GmbH, Австрия |
Genericon Pharma GmbH, Austria |
8 |
1.6 |
9.6 |
7% |
0.56 |
8.56 |
1.71 |
10.27 |
20% |
1.6 |
10.16 |
2.03 |
12.19 |
НСР-9506/09.06.2016 |
02.07.2016 |
02.07.2016 |
|
|
Неактивен |
15111 |
| Omeprazole |
12052/13.12.2005 г. |
OMEPROZONE, Capsules, 20 mg, -, Pack: 28 |
Ozone Laboratories LTD, Обединено Кралство |
Laboratorious Belmac S.A., Spain |
5.53 |
1.11 |
6.64 |
7% |
0.39 |
5.92 |
1.18 |
7.1 |
20% |
1.11 |
7.03 |
1.41 |
8.44 |
КЦ-981/
25,06,2009 г. |
13.07.2009 |
13.07.2009 |
|
|
Активен |
7602 |
| Omeprazole |
12052/13.12.2005 г. |
OMEPROZONE, Capsules, 20 mg, -, Pack: 14 |
Ozone Laboratories LTD, Обединено Кралство |
Laboratorious Belmac S.A., Spain |
3.32 |
0.66 |
3.98 |
7% |
0.23 |
3.55 |
0.71 |
4.26 |
20% |
0.66 |
4.21 |
0.84 |
5.05 |
КЦ-981/
25,06,2009 г. |
13.07.2009 |
13.07.2009 |
|
|
Активен |
7601 |
| Testosterone |
№ ІІ 5161/ 08.06.2010 |
Omnadren, -, 250 mg/ml - 5 ml, -, Pack: 5 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Jelfa SA,21 Wincentego Pola Str., Poland |
13.69 |
2.74 |
16.43 |
6% |
0.82 |
14.51 |
2.9 |
17.41 |
18% |
2.46 |
16.97 |
3.39 |
20.36 |
КЦ-1934/
17,01,2011 г. |
02.02.2011 |
02.02.2011 |
промяна на обстоятелства НСР-2350/21.01.2014 |
|
Активен |
7853 |
| Somatropin |
EU/1/06/332/008 |
Omnitrop, Solution for injection, 6.7 mg(20 IU/ml x 1.5 ml), -, Pack: 5 |
Sandoz GmbH, Австрия |
Sandoz GmbH |
1369.08 |
273.82 |
1642.9 |
4% |
10 |
1379.08 |
275.82 |
1654.9 |
16% |
25 |
1404.08 |
280.82 |
1684.9 |
КЦ-2545/15.08.2011 г. |
30.08.2011 |
30.08.2011 |
|
|
Заличен |
1500 |
| Somatropin |
EU/1/06/332/005 |
Omnitrop, Solution for injection, 3.3 mg(10 IU/ml x 1.5 ml), -, Pack: 5 |
Sandoz GmbH, Австрия |
Sandoz GmbH |
684.54 |
136.91 |
821.45 |
4% |
10 |
694.54 |
138.91 |
833.45 |
16% |
25 |
719.54 |
143.91 |
863.45 |
КЦ-2545/15.08.2011 г. |
30.08.2011 |
30.08.2011 |
|
|
Заличен |
1499 |
| Somatropin |
EU/1/06/332/005 |
Omnitropе, Solution for injection, 5 mg(15 IU) /1.5 ml, IU, Pack: 5 cartridge |
Sandoz GmbH, Австрия |
Sandoz GmbH - Austria |
635.64 |
127.13 |
762.77 |
4% |
10 |
645.64 |
129.13 |
774.77 |
16% |
25 |
670.64 |
134.13 |
804.77 |
НСР-11646/03.02.2017 |
02.03.2017 |
02.03.2017 |
|
|
Активен |
1499 |
| Somatropin |
EU/1/06/332/008 |
Omnitropе, Solution for injection, 10 mg (30 IU)/1.5 ml, -, Pack: 5 cartridge |
Sandoz GmbH, Австрия |
Sandoz GmbH, Austria |
1212.61 |
242.52 |
1455.13 |
4% |
10 |
1222.61 |
244.52 |
1467.13 |
16% |
25 |
1247.61 |
249.52 |
1497.13 |
НСР-11647/03.02.2017 |
02.03.2017 |
02.03.2017 |
|
|
Активен |
1500 |
| Olopatadine |
EU/1/02/217/001 |
Opatanol, Eye drops, solution, 1 mg/ml - 5 ml, -, Pack: 1 |
Novartis Europharm Limited, Ирландия |
S.A. Alcon-Couvreur N.V.,Белгия;Alcon Cusí, S.A., Испания |
8.04 |
1.61 |
9.65 |
7% |
0.56 |
8.6 |
1.72 |
10.32 |
20% |
1.61 |
10.21 |
2.04 |
12.25 |
НСР-1603/01.11.2013 |
22.11.2013 |
02.08.2018 |
Промяна на обстоятелства НСР-13062/23.06.2017; НСР-16143/13.07.2018 |
|
Активен |
8542 |
| Olopatadine |
EU/1/02/217/001 |
Opatanol, Eye drops, solution, 1 mg/ml - 5 ml, -, Pack: 1 |
Novartis Europharm Limited, Обединено Кралство |
S.A. Alcon-Couvreur N.V.,Белгия;Alcon Cusí, S.A., Испания |
8.04 |
1.61 |
9.65 |
7% |
0.56 |
8.6 |
1.72 |
10.32 |
20% |
1.61 |
10.21 |
2.04 |
12.25 |
НСР-1603/01.11.2013 |
22.11.2013 |
02.08.2017 |
Промяна на обстоятелства НСР-13062/23.06.2017 |
|
Неактивен |
8542 |
| Olopatadine |
EU/1/02/217/001 |
Opatanol, Eye drops, solution, 1 mg/ml - 5 ml, -, Pack: 1 |
Alcon Laboratories (UK) Ltd., Обединено Кралство |
S.A. Alcon-Couvreur N.V.,Белгия;Alcon Cusí, S.A., Испания |
8.04 |
1.61 |
9.65 |
7% |
0.56 |
8.6 |
1.72 |
10.32 |
20% |
1.61 |
10.21 |
2.04 |
12.25 |
НСР-1603/01.11.2013 |
22.11.2013 |
22.11.2013 |
|
|
Неактивен |
8542 |
| Loversol |
II-12639/16.03.2006 г. |
OPTIRAY, Solution for injection, 300 mg/ml 75 ml, -, Pack: 10 |
Covidien Deutschland GmbH,, Германия |
Covidien Deutschland GmbH - Germany |
491.4 |
98.28 |
589.68 |
4% |
10 |
501.4 |
100.28 |
601.68 |
16% |
25 |
526.4 |
105.28 |
631.68 |
КЦ-2042/
28,02,2011 г.; НСР-13526/18.08.2017 |
14.03.2011 |
02.10.2017 |
|
|
Заличен |
7490 |
| Loversol |
II-12639/16.03.2006 г. |
OPTIRAY, Solution for injection, 300 mg/ml 75 ml, -, Pack: 10 |
Covidien Deutschland GmbH,, Германия |
Covidien Deutschland GmbH - Germany |
491.4 |
98.28 |
589.68 |
4% |
10 |
501.4 |
100.28 |
601.68 |
16% |
25 |
526.4 |
105.28 |
631.68 |
КЦ-2042/
28,02,2011 г. |
14.03.2011 |
14.03.2011 |
|
|
Неактивен |
7490 |
| Ioversol |
14109/15.08.2006 |
OPTIRAY 300, sol.inj./inf., 300 mg mg/ml - 50 ml, -, Pack: спринцовки под налягане x 10 |
Tyco Healthcare Deutschland GmbH, Германия |
Tyco Healthcare, Canada; Mallinckrodt inc., USA; Mallinckrodt Medical Imaging, Ireland |
369.77 |
73.95 |
443.72 |
4% |
10 |
379.77 |
75.95 |
455.72 |
16% |
25 |
404.77 |
80.95 |
485.72 |
КЦ-226/
19,09,2008 г.; НСР-13526/18.08.2017 |
22.10.2008 |
02.10.2017 |
|
|
Заличен |
1607 |
| Ioversol |
14109/15.08.2006 |
OPTIRAY 300, sol.inj./inf., 300 mg mg/ml - 50 ml, -, Pack: спринцовки под налягане x 10 |
Tyco Healthcare Deutschland GmbH, Германия |
Tyco Healthcare, Canada; Mallinckrodt inc., USA; Mallinckrodt Medical Imaging, Ireland |
369.77 |
73.95 |
443.72 |
4% |
10 |
379.77 |
75.95 |
455.72 |
16% |
25 |
404.77 |
80.95 |
485.72 |
КЦ-226/
19,09,2008 г. |
22.10.2008 |
22.10.2008 |
|
|
Неактивен |
1607 |
| Ioversol |
14110/15.08.2006 |
OPTIRAY 320, sol.inj./inf., 320 mg mg/ml - 50 ml, -, Pack: предварително напълнени ръчни спринцовки x 10 |
Tyco Healthcare Deutschland GmbH, Германия |
Tyco Healthcare, Canada; Mallinckrodt inc., USA; Mallinckrodt Medical Imaging, Ireland |
408.67 |
81.73 |
490.4 |
4% |
10 |
418.67 |
83.73 |
502.4 |
16% |
25 |
443.67 |
88.73 |
532.4 |
КЦ-226/
19,09,2008 г.; НСР-13526/18.08.2017 |
22.10.2008 |
02.10.2017 |
|
|
Заличен |
1605 |
| Ioversol |
14110/15.08.2006 |
OPTIRAY 320, sol.inj./inf., 320 mg mg/ml - 50 ml, -, Pack: предварително напълнени ръчни спринцовки x 10 |
Tyco Healthcare Deutschland GmbH, Германия |
Tyco Healthcare, Canada; Mallinckrodt inc., USA; Mallinckrodt Medical Imaging, Ireland |
408.67 |
81.73 |
490.4 |
4% |
10 |
418.67 |
83.73 |
502.4 |
16% |
25 |
443.67 |
88.73 |
532.4 |
КЦ-226/
19,09,2008 г. |
22.10.2008 |
22.10.2008 |
|
|
Неактивен |
1605 |
| Ioversol |
14110/15.08.2006 |
OPTIRAY 320, Solution for injection/infusion, 320 mg mg/ml - 75 ml, -, Pack: спринцовки под налягане x 10 |
Tyco Healthcare Deutschland GmbH, Германия |
Tyco Healthcare, Canada; Mallinckrodt inc., USA; Mallinckrodt Medical Imaging, Ireland |
510.75 |
102.15 |
612.9 |
4% |
10 |
520.75 |
104.15 |
624.9 |
16% |
25 |
545.75 |
109.15 |
654.9 |
КЦ-226/
19,09,2008 г.; НСР-13526/18.08.2017 |
22.10.2008 |
02.10.2017 |
|
|
Заличен |
7426 |
| Ioversol |
14110/15.08.2006 |
OPTIRAY 320, Solution for injection/infusion, 320 mg mg/ml - 75 ml, -, Pack: спринцовки под налягане x 10 |
Tyco Healthcare Deutschland GmbH, Германия |
Tyco Healthcare, Canada; Mallinckrodt inc., USA; Mallinckrodt Medical Imaging, Ireland |
510.75 |
102.15 |
612.9 |
4% |
10 |
520.75 |
104.15 |
624.9 |
16% |
25 |
545.75 |
109.15 |
654.9 |
КЦ-226/
19,09,2008 г. |
22.10.2008 |
22.10.2008 |
|
|
Неактивен |
7426 |